Citation 6800
PERRY,NSL: HOUGHTON,PJ: SAMPSON,J: THEOBALD,AE: HART,S: LIS-BALCHIN,M: HOULT,JRS: EVANS,P: JENNER,P: MILLIGAN,S: PERRY,EK:. (2001). IN-VITRO ACTIVITY OF S. LAVANDULAEFOLIA (SPANISH AGE) RELEVANT TO TREATMENT OF ALZHEIMER'S DISEASE.. 53(10)
Citation Details
| Title | IN-VITRO ACTIVITY OF S. LAVANDULAEFOLIA (SPANISH AGE) RELEVANT TO TREATMENT OF ALZHEIMER'S DISEASE. |
|---|---|
| Authors | PERRY,NSL: HOUGHTON,PJ: SAMPSON,J: THEOBALD,AE: HART,S: LIS-BALCHIN,M: HOULT,JRS: EVANS,P: JENNER,P: MILLIGAN,S: PERRY,EK: |
| Year | 2001 |
| Volume | 53 |
| Issue | 10 |
Summary
Year: 2001
Journal: Unknown
Organisms and Their Experiments (1)
Salvia lavandulaefolia (LAMIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 |
LIPID PEROXIDE FORMATION INHIBITION
| None |
EQUIVOCAL
|
|
| 2 |
LEUKOTRIENE B-4 INHIBITION
| None |
WEAK ACTIVITY
|
|
| 3 |
THROMBOXAN B2 RELEASE INHIBITION
| None |
ACTIVE
|
|
| 4 |
LIPID PEROXIDE FORMATION INHIBITION
| None |
EQUIVOCAL
|
|
| 5 |
LEUKOTRIENE B-4 INHIBITION
| None |
WEAK ACTIVITY
|
|
| 6 |
THROMBOXAN B2 RELEASE INHIBITION
| None |
ACTIVE
|
|
| 7 |
LIPID PEROXIDE FORMATION INHIBITION
| None |
EQUIVOCAL
|
|
| 8 |
LEUKOTRIENE B-4 INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
THROMBOXAN B2 RELEASE INHIBITION
| None |
ACTIVE
|
|
| 10 |
ESTROGENIC EFFECT
| None |
ACTIVE
|
|
| 11 |
ESTROGENIC EFFECT
| None |
EQUIVOCAL
|
|
| 12 |
ESTROGENIC EFFECT
| None |
INACTIVE
|
|
| 13 |
ESTROGENIC EFFECT
| None |
ACTIVE
|
|
| 14 | Not specified | None | ||
| 15 |
LIPID PEROXIDE FORMATION INHIBITION
|
ACTIVE
|
||
| 16 |
LEUKOTRIENE B-4 INHIBITION
|
INACTIVE
|
||
| 17 |
THROMBOXAN B2 RELEASE INHIBITION
|
ACTIVE
|
||
| 18 |
ESTROGENIC EFFECT
|
ACTIVE
|
||
| 19 | Not specified | None | ||
| 20 |
LIPID PEROXIDE FORMATION INHIBITION
|
ACTIVE
|
||
| 21 |
ESTROGENIC EFFECT
|
ACTIVE
|
||
| 22 | Not specified | None | ||
| 23 |
LIPID PEROXIDE FORMATION INHIBITION
|
ACTIVE
|
||
| 24 |
LEUKOTRIENE B-4 INHIBITION
|
INACTIVE
|
||
| 25 |
THROMBOXAN B2 RELEASE INHIBITION
|
INACTIVE
|
||
| 26 |
ESTROGENIC EFFECT
|
ACTIVE
|
||
| 27 | Not specified | None | ||
| 28 |
LIPID PEROXIDE FORMATION INHIBITION
|
ACTIVE
|
||
| 29 |
LEUKOTRIENE B-4 INHIBITION
|
INACTIVE
|
||
| 30 |
THROMBOXAN B2 RELEASE INHIBITION
|
WEAK ACTIVITY
|
||
| 31 |
ESTROGENIC EFFECT
|
ACTIVE
|
||
| 32 | Not specified | None | ||
| 33 |
LIPID PEROXIDE FORMATION INHIBITION
|
INACTIVE
|
||
| 34 |
LEUKOTRIENE B-4 INHIBITION
|
INACTIVE
|
||
| 35 |
THROMBOXAN B2 RELEASE INHIBITION
|
INACTIVE
|
||
| 36 | Not specified | None | ||
| 37 |
LIPID PEROXIDE FORMATION INHIBITION
|
ACTIVE
|
||
| 38 |
LEUKOTRIENE B-4 INHIBITION
|
ACTIVE
|
||
| 39 |
THROMBOXAN B2 RELEASE INHIBITION
|
INACTIVE
|
||
| 40 |
ESTROGENIC EFFECT
|
ACTIVE
|